A Study of Comparing Rates of Dementia and Alzheimer's Disease in Participants Initiating Methotrexate Versus Those Initiating Anti-tumor Necrosis Factor (TNF)-Alpha Therapy
Clinical trial NCT04571697 · COMPLETED
Trial details
- NCT number
- NCT04571697
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2020-09-28
- Primary completion
- 2020-10-27
- Enrollment
- 34647
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.